Based on the Invesco Dynamic Pharmaceuticals ETF stock forecast from 0 analysts, the average analyst target price for Invesco Dynamic Pharmaceuticals ETF is not available over the next 12 months. Invesco Dynamic Pharmaceuticals ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Invesco Dynamic Pharmaceuticals ETF is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Invesco Dynamic Pharmaceuticals ETF’s stock price was USD 75.65. Invesco Dynamic Pharmaceuticals ETF’s stock price has changed by +0.43% over the past week, -4.38% over the past month and -2.80% over the last year.
No recent analyst target price found for Invesco Dynamic Pharmaceuticals ETF
No recent average analyst rating found for Invesco Dynamic Pharmaceuticals ETF
Company Overview Invesco Dynamic Pharmaceuticals ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified. Read Less
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufact...Read More
Frequently Asked Questions About Invesco Dynamic Pharmaceuticals ETF (PJP) Stock
Stock Target Advisor's fundamental analysis for Invesco Dynamic Pharmaceuticals ETF's stock is Slightly Bullish .
PJP stock's dividend yield is 0.92%.
Our analysis grades PJP stock's dividend yield at F. This means that PJP stock's dividend yield is above 56% of the stocks in the Health sector in the NYE exchange.
Based on this PJP may be a average dividend stock for its sector.
Unfortunately we do not have enough data on PJP's stock to indicate what its average analyst target is.
PJP stock's Price/Earning ratio is 3.22.
Our analysis grades PJP stock's Price / Earning ratio at A. This means that PJP stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Health sector in the NYE exchange.
Based on this PJP may be undervalued for its sector.
The last closing price of PJP's stock was USD 75.65.
The most recent market capitalization for PJP is USD 0.26B.
Unfortunately we do not have enough analyst data on PJP's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Invesco Dynamic Pharmaceuticals ETF's stock.
As per our most recent records Invesco Dynamic Pharmaceuticals ETF has 364,000 Employees.
Invesco Dynamic Pharmaceuticals ETF's registered address is WTC Tower H, Amsterdam, Netherlands, 1077 XV.
You can get more information about it from Invesco Dynamic Pharmaceuticals ETF's website at http://www.invesco.com/us.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PJP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
